Papers considered for publication must contain original material that has not been published, either in full or in part (including tables and figures), nor has been submitted to or accepted for publication by other journals. Before sending the manuscripts, authors must obtain all permissions needed for publication of the presented material. Note that, to comply with regulations governing authors’ rights, the reproduction of images, figures, or graphs from other publications must have the respective authors’ prior authorization, who should be included in the references. 

The opinions expressed are of the authors’ exclusive responsibility and may not express the opinion of editors and editorial board members. 

The recommendations stipulated by the Committee on Publication Ethics regarding the use of artificial intelligence in scientific research writing, will be strictly followed. 

Authors at the time of submission, must declare whether artificial intelligence (AI)– assisted technologies (such as Large Language Models [LLMs], chatbots, or image creators) in the production of submitted work and describe, in both the cover letter and the submitted work, how they used it. 

Chatbots (such as ChatGPT) should not be listed as authors because they cannot be responsible for the accuracy, integrity, and originality of the work, and these responsibilities are required for authorship. Therefore, humans are responsible for any submitted material that included the use of AI-assisted technologies. Authors should not list AI and AI assisted technologies as an author or co-author, nor cite AI as an author. Humans must ensure there is appropriate attribution of all quoted material, including full citations. 

Reviewers who choose to use AI-assisted technologies to support the review process must declare their use to the editorial team and are responsible for ensuring that any AI-generated content incorporated into the review is accurate and unbiased. 

The articles must be sent to the Editor, accompanied by a cover letter and declaration of authorship and/or conflict of interest, with the transfer of copyright and authorization for publication in Portuguese Journal of Immunoallergology. The articles must be submitted online on the website

Portuguese Journal of Immunoallergology is an open-access journal, meaning all content is freely available to the user or his institution without charge. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles or use them for any other lawful purpose without asking the publisher's or the author's prior permission. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of open access. 
All papers published in the Portuguese Journal of Immunoallergology are fully open access since January 2024 under the Creative Commons user license (https://creativecommons.org/licenses/by-nc-nd/4.0/ ) : Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND 4.0).
 

This license allows third parties to share the publication if they attribute proper authorship to the authors and do not use the work for commercial purposes. Adhering to this license ensures that the work is accessible to as many readers as possible, promoting the dissemination of knowledge while protecting the authors' rights and restricting commercial use and the creation of unauthorized derivative versions.
 

A complete version of the work and all supplemental materials in a suitable standard electronic format are deposited immediately upon initial publication on the journal website (https://rpia.spaic.pt/ ), which is an online repository supported by the scholarly society SPAIC - Sociedade Portuguesa de Imunolaergologia.

Open Access Publication Fee
No fee is payable by the author as publishing costs are covered by the society.

At the time of article submission, authors are requested to provide a "Publication Authorization Document for the Journal." This authorization implies that should the article be accepted for publication the authors agree to publish it under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0). Acceptance of the agreement will ensure the broadest possible dissemination of information.

Copyright will be transferred to the society SPAIC - Sociedade Portuguesa de Imunolaergologia if the manuscript is accepted for publication.
 

Permission of the society is required for resale or distribution outside the institution and for all other derivative works, including compilations and translations.